Deep Track Capital as of Dec. 31, 2022
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 58 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunovant (IMVT) | 7.2 | $172M | 9.7M | 17.75 | |
| Iveric Bio | 7.1 | $169M | 7.9M | 21.41 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.8 | $139M | 874k | 159.31 | |
| Ascendis Pharma A/s Sponsored Adr Call Option (ASND) | 4.9 | $116M | 949k | 122.13 | |
| Horizon Therapeutics Pub L SHS | 4.8 | $114M | 1.0M | 113.80 | |
| Travere Therapeutics (TVTX) | 4.0 | $96M | 4.6M | 21.03 | |
| Insmed Com Par $.01 (INSM) | 3.6 | $85M | 4.3M | 19.98 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.5 | $83M | 2.8M | 29.60 | |
| Verona Pharma Sponsored Ads (VRNA) | 3.5 | $83M | 3.2M | 26.13 | |
| Biogen Idec (BIIB) | 3.5 | $83M | 300k | 276.92 | |
| Springworks Therapeutics (SWTX) | 3.4 | $81M | 3.1M | 26.01 | |
| Chinook Therapeutics | 3.3 | $79M | 3.0M | 26.20 | |
| Sarepta Therapeutics (SRPT) | 2.9 | $68M | 528k | 129.58 | |
| Agenus Com New | 2.7 | $65M | 27M | 2.40 | |
| 4d Molecular Therapeutics In (FDMT) | 2.5 | $59M | 2.7M | 22.21 | |
| Dice Therapeutics | 2.3 | $54M | 1.7M | 31.20 | |
| Miragen Therapeutics (VRDN) | 2.2 | $52M | 1.8M | 29.21 | |
| 89bio (ETNB) | 2.1 | $49M | 3.9M | 12.73 | |
| Beam Therapeutics (BEAM) | 1.9 | $46M | 1.2M | 39.11 | |
| Ionis Pharmaceuticals (IONS) | 1.9 | $46M | 1.2M | 37.77 | |
| Allakos (ALLK) | 1.7 | $41M | 4.9M | 8.42 | |
| Repare Therapeutics Ord (RPTX) | 1.7 | $40M | 2.7M | 14.71 | |
| Albireo Pharma | 1.5 | $37M | 1.7M | 21.61 | |
| Pliant Therapeutics (PLRX) | 1.4 | $34M | 1.7M | 19.33 | |
| Dyne Therapeutics (DYN) | 1.3 | $31M | 2.7M | 11.59 | |
| Edgewise Therapeutics (EWTX) | 1.3 | $30M | 3.4M | 8.94 | |
| Silence Therapeutics Ads (SLN) | 1.2 | $30M | 2.0M | 15.25 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.2 | $29M | 15M | 1.90 | |
| Astria Therapeutics (ATXS) | 1.1 | $27M | 1.8M | 14.89 | |
| Vigil Neuroscience (VIGL) | 1.1 | $26M | 2.1M | 12.50 | |
| Rapt Therapeutics (RAPT) | 1.1 | $26M | 1.3M | 19.80 | |
| Esperion Therapeutics (ESPR) | 1.0 | $25M | 4.0M | 6.23 | |
| Nurix Therapeutics (NRIX) | 1.0 | $25M | 2.3M | 10.98 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.0 | $25M | 2.3M | 10.64 | |
| Intellia Therapeutics (NTLA) | 1.0 | $24M | 700k | 34.89 | |
| Acumen Pharmaceuticals (ABOS) | 0.9 | $21M | 4.0M | 5.40 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $20M | 190k | 103.49 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $19M | 1.0M | 18.30 | |
| Geron Corporation (GERN) | 0.8 | $18M | 7.4M | 2.42 | |
| Heron Therapeutics (HRTX) | 0.7 | $16M | 6.5M | 2.50 | |
| Nuvation Bio Com Cl A (NUVB) | 0.7 | $16M | 8.2M | 1.92 | |
| Syndax Pharmaceuticals (SNDX) | 0.5 | $13M | 500k | 25.45 | |
| Relmada Therapeutics (RLMD) | 0.4 | $9.9M | 2.8M | 3.49 | |
| Protagonist Therapeutics (PTGX) | 0.4 | $9.5M | 872k | 10.91 | |
| Nkarta (NKTX) | 0.3 | $8.1M | 1.4M | 5.99 | |
| Avidity Biosciences Ord (RNA) | 0.3 | $6.7M | 300k | 22.19 | |
| Viking Therapeutics (VKTX) | 0.2 | $5.7M | 610k | 9.40 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $5.6M | 769k | 7.28 | |
| Gh Research Ordinary Shares (GHRS) | 0.2 | $4.9M | 499k | 9.72 | |
| Jounce Therapeutics | 0.2 | $4.7M | 4.3M | 1.11 | |
| Century Therapeutics (IPSC) | 0.1 | $3.6M | 696k | 5.13 | |
| Inozyme Pharma (INZY) | 0.1 | $3.4M | 3.3M | 1.05 | |
| Assembly Biosciences | 0.1 | $2.4M | 1.8M | 1.30 | |
| Third Harmonic Bio (THRD) | 0.1 | $1.9M | 446k | 4.30 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $1.4M | 324k | 4.32 | |
| Magenta Therapeutics | 0.0 | $1.2M | 3.0M | 0.40 | |
| Hookipa Pharma Inc equity | 0.0 | $1.0M | 1.2M | 0.81 | |
| Reata Pharmaceuticals Cl A Call Option | 0.0 | $479k | 13k | 37.99 |
